Purpose. Model compounds containing NO-donor furoxan moieties at the 3-posi
tioned basic lateral chain of 1, a 1,4-dihydropyridine related to nicardipi
ne, were synthesized in order to study their vasodilating activity as well
as their basic and lipophilic behaviour.
Methods. All the compounds were obtained by a modified Hantzsch approach. P
otentiometry was used to determine pK(a) and lipophilicity descriptors. The
furoxan 4-aryl-1,4-dihydropyridines were assessed for their ability to rel
ease nitrite, in the presence of a large excess of cysteine, by the Griess
reaction. Vasodilating activity of the products in the absence and in the p
resence of ODQ, a well-known guanylate cyclase inhibitor, was evaluated on
rat thoracic aorta.
Results, The compounds display low basicity values and for this reason thei
r log Ds at physiological pH are identical to the log Ps of the neutral for
ms. Products 2, 3 display vasodilating action principally dependent on thei
r Ca2+-antagonist properties, whereas 4 behaves as a well-balanced hybrid w
ith mixed Ca2+-channel blocker and NO-dependent vasodilator activities.
Conclusions. Nitrogen containing lateral chain at the 3-position of 1 is a
suitable molecular region to be modified in order to obtain well-balanced f
uroxan NO-donor 1,4-DHPs. This manipulation produces a decrease in the basi
city. General analysis of pK(a) and lipophilicity descriptors of these new
DHPs suggest that molecular flexibility could influence both their basicity
and log P-1.